ATS 2018 International Conference

Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST [Board No. 405]

Location: Board no. 405

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Ian Pavord

MD, DM
Nuffield Department of Medicine and Oxford NIHR BRC, University of Oxford;Oxford University Hospitals NHS Foundation Trust;University of Oxford

Jaman Maroni

MD
Regeneron Pharmaceuticals, Inc.

Neil M.H. Graham

MD, MPH, MBBS
Regeneron Pharmaceuticals, Inc.

Sally E. Wenzel

MD
Univ of Pittsburgh Med Ctr;Universirty of Pittsburgh;University of Pittsburgh;University of Pittsburgh Medical Center

Bingzhi Zhang

PhD
Sanofi

Ariel Teper

MD
Sanofi

Brian N. Swanson

PhD
Sanofi

Nikhil Amin

MD
Regeneron Pharmaceuticals, Inc.

Paul Rowe

MD
Sanofi

Jennifer D. Hamilton

PhD
Regeneron Pharmaceuticals, Inc.

Gianluca Pirozzi

MD, PhD
Sanofi

View Abstract

Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST

Parent Sessions

C101 - ASTHMA CLINICAL AND MECHANISTIC STUDIES...
05-22-2018 2:15 PM - 4:15 PM

Event